New non-invasive prenatal test confirms high-risk results with accuracy matching invasive methods.

BillionToOne launched Unity Confirm, a non-invasive prenatal test that captures intact fetal cells from maternal blood to confirm high-risk screening results. This test offers a safer alternative to invasive procedures like amniocentesis, which carry risks and are often declined by patients. Unity Confirm provides diagnostic-level accuracy by sequencing whole fetal cells, bridging the gap between screening and invasive diagnostics. It will be available to patients using Unity Aneuploidy screening starting May 28, 2026, with ongoing studies to validate its performance on a larger scale.